Egalet Corporation (Nasdaq: EGLT) to Ring The Nasdaq Stock Market Closing Bell
March 29 2017 - 10:48AM
What:Egalet Corporation
(Nasdaq:EGLT), a fully integrated specialty pharmaceutical company
focused on developing, manufacturing and commercializing innovative
treatments for pain and other conditions, will visit the Nasdaq
MarketSite in Times Square.
In honor of the occasion, Robert Radie,
President and CEO, will ring the Closing Bell.
Where:Nasdaq MarketSite – 4 Times Square – 43rd
& Broadway – Broadcast Studio
When:Thursday, March 30, 2017 – 3:45 p.m. to
4:00 p.m. ET
Egalet Contact:E. Blair Clark-SchoebSenior Vice
President, Communicationsbcs@egalet.com917-432-9275
Nasdaq MarketSite:Emily Pan(646)
441-5120emily.pan@nasdaq.com
Feed Information:Fiber Line (Encompass
Waterfront): 4463
Gal 3C/06C 95.05 degrees West 18 mhz Lower DL 3811 Vertical FEC
3/4 SR 13.235 DR 18.295411 MOD 4:2:0 DVBS QPSK
Social Media:For multimedia features such as
exclusive content, photo postings, status updates and video of bell
ceremonies, please visit our Facebook
page:http://www.facebook.com/NASDAQ.
For photos from ceremonies and events, please visit our
Instagram page:http://instagram.com/nasdaq
For livestream of ceremonies and events, please visit our
YouTube page:http://www.youtube.com/nasdaq/live
For news tweets, please visit our Twitter
page:http://twitter.com/nasdaq
For exciting viral content and ceremony photos, please visit our
Tumblr page:http://nasdaq.tumblr.com/
Webcast:A live stream of the Nasdaq Closing
Bell will be available at: https://new.livestream.com/nasdaq/live
or http://www.nasdaq.com/about/marketsitetowervideo.asx
Photos: To obtain a hi-resolution photograph of
the Market Close, please go to
http://business.nasdaq.com/discover/market-bell-ceremonies and
click on the market close of your choice.
About Egalet Egalet, a fully integrated
specialty pharmaceutical company, is focused on developing,
manufacturing and commercializing innovative treatments for pain
and other conditions. Egalet has three approved products: ARYMO™ ER
(morphine sulfate) extended-release tablets for oral use only –CII,
developed using Egalet's proprietary Guardian™
Technology, OXAYDO® (oxycodone HCI, USP) tablets for oral use
only –CII and SPRIX® (ketorolac tromethamine) Nasal
Spray. Using Guardian Technology, Egalet is developing a pipeline
of clinical-stage, product candidates including Egalet-002, an
abuse-deterrent, extended-release, oral oxycodone formulation for
the management of pain severe enough to require daily,
around-the-clock, long-term opioid treatment and for which
alternative treatment options are inadequate. Guardian Technology
can be applied broadly across different classes of pharmaceutical
products and can be used to develop combination products that
include multiple active pharmaceutical ingredients with similar or
different release profiles. For full prescribing information on
ARYMO ER, including the boxed warning and medication guide, please
visit arymoer.com. For full prescribing information on SPRIX,
including the boxed warning and medication guide, please
visit sprix.com. For full prescribing information on OXAYDO,
including the boxed warning and medication guide, please
visit oxaydo.com. For additional information on Egalet, please
visit egalet.com.
About Nasdaq
Nasdaq (Nasdaq:NDAQ) is a leading provider of trading, clearing,
exchange technology, listing, information and public company
services across six continents. Through its diverse portfolio of
solutions, Nasdaq enables clients to plan, optimize and execute
their business vision with confidence, using proven technologies
that provide transparency and insight for navigating today's global
capital markets. As the creator of the world's first
electronic stock market, its technology powers more than 85
marketplaces in 50 countries, and 1 in 10 of the world's securities
transactions. Nasdaq is home to approximately 3,800 listed
companies with a market value of $10.1 trillion and nearly 18,000
corporate clients. To learn more, visit: business.nasdaq.com.
-NDAQA-
Nasdaq (NASDAQ:NDAQ)
Historical Stock Chart
From Mar 2024 to Apr 2024
Nasdaq (NASDAQ:NDAQ)
Historical Stock Chart
From Apr 2023 to Apr 2024